The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

Breadcrumbs

DIR 217

Commercial supply of nadofaragene firadenovec for bladder cancer treatment

Licence details

Licence number:
DIR 217
Licence status:
Application under evaluation
Category:
Medical
Release:
Commercial
Organisation:

Ferring Pharmaceuticals Pty Ltd

Date application received:

Documents

Licence application - notification

Information for the public and stakeholders that the Regulator has received an application for a licence. It provides early information about the application and the assessment process including a future opportunity for public submissions.

Licence application - Q&A

FAQs on the licence application and a brief outline of the assessment and public consultation processes.

Licence application - summary

A summary of the application including brief description of the GMO(s) and proposed work with GMO(s). Also explains the assessment and public consultation process.

Last updated: